JFrog stock rises as Cantor Fitzgerald maintains Overweight rating after strong Q2
FRISCO, Texas—Brian Poff, the Executive Vice President and Chief Financial Officer of Addus HomeCare Corp (NASDAQ:ADUS), recently sold 3,164 shares of the company’s common stock. The transaction, which took place on February 24, 2025, was executed at a price of $108.18 per share, amounting to a total value of approximately $342,281. The company, with a market capitalization of $1.7 billion, maintains strong financial health with a "GREAT" rating according to InvestingPro metrics.
The sale was conducted under a previously established 10b5-1 plan, a common strategy used by insiders to avoid potential accusations of insider trading. The proceeds from this sale are intended to cover tax obligations related to the vesting of restricted stock awards granted by Addus HomeCare.
Earlier, on February 21, 2025, Poff acquired 13,732 shares of common stock at no cost. These shares will vest in equal installments over the next three years, contingent upon continued service and potential acceleration in the event of a change in control.
Following these transactions, Poff holds 35,273 shares directly. Addus HomeCare, headquartered in Frisco, Texas, provides home health care services and is incorporated in Delaware. The company has demonstrated solid performance with a 10.15% revenue growth in the last twelve months and maintains healthy profit margins of 32.5%.
In other recent news, Addus HomeCare Corporation reported its fourth-quarter 2024 earnings, surpassing expectations with an earnings per share (EPS) of $1.38 against a forecast of $1.35. The company’s revenue also exceeded projections, reaching $297.1 million compared to the anticipated $284.28 million. Addus HomeCare completed a significant acquisition, integrating Gentiva Personal Care, which added approximately $280 million in annualized revenues and expanded market coverage. Despite these positive results, the company faces challenges, including potential changes in Medicaid policy and a competitive labor market, particularly for clinical staff. Addus HomeCare’s strategic focus remains on mergers and acquisitions, with plans to continue leveraging its strong balance sheet for future deals. Analysts have noted the company’s robust growth strategy, with a full-year revenue increase of 9.1% to $1.2 billion. The firm aims for a 10% annual revenue growth and anticipates significant expansion in its hospice segment. Additionally, Addus HomeCare has been recognized for its leadership in home-based care, emphasizing its position as a low-cost provider in the industry.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.